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Abstract. Three diﬀerent methods of sedation or sedoan-
algesia using remifentanil, Propofol, or midazolam to in-
crease intra- and postoperative comfort and to reduce
neuroendocrine stress in patients who had undergone typ-
ical ambulatory cosmetic surgery under local anesthesia
were studied. A sample of 90 patients who underwent upper
and lower eyelid blepharoplasty to correct baggy eyelids or
otoplasty to correct protruding ears was selected according
to standard criteria for the study. Remifentanil provided
the best tolerability proﬁle and the most eﬀective periop-
erative pain control among the substances studied, dem-
onstrating it to be a valid drug for modern sedoanalgesia
aimed at increasing the well-being of patients undergoing
ambulatory cosmetic surgery.
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Currently, the search for pharmacologic agents that
improve comfort for patients undergoing ambulatory
cosmetic surgery is increasingly important. Certainly,
the objective for these drugs is to increase the safety
and eﬀectiveness of the anesthesia procedure con-
temporaneously, allowing eﬃcient postoperative
analgesia and rapid recovery of the patient, thus
reducing hospitalization. Three diﬀerent methods of
sedation or sedoanalgesia using remifentanil, propo-
fol, or midazolam to reduce intra- and postoperative
pain and neuroendocrine stress in patients who had
undergone typical ambulatory cosmetic surgery un-
der local anaesthesia were studied.
Midazolam is a hydrosoluble benzodiazepine, the
ﬁrst produced for anaesthetic purposes [13]. Propofol
is an endovenous anesthetic that belongs to the alkyl
phenols (oils at room temperature and therefore
insoluble in water, but highly liposoluble) [3]. Rem-
ifentanil is an opioid with rapid onset, metabolized by
nonspeciﬁc, nonsaturated hematic and tissue ester-
ases [1].
Blepharoplasty and otoplasty, the two types of
cosmetic surgery most frequently performed in out-
patient settings, were chosen for this study. Both have
similar operating times, sedation intensity, and
postoperative analgesia duration.
Materials and Methods
With written consent, 90 patients (64 females and 26
males) ages 18 to 67 years (average, 46 ± 8 years)
were studied. These patients had an American Society
of Anesthesiology (ASA) classiﬁcation of I or II, and
a body weight of 52 to 88 kg (average 67 ± 9 kg).
They had undergone cosmetic blepharoplasty surgery
for upper and lower eyelid bags or otoplasty for
protruding ears. The average operating time was
68 ± 11 minutes and for blepharoplasty 56 ± 8
minutes for otoplasty.
The patients were divided into three homogeneous
groups according to their age, weight, ASA class, and
type of surgery. The propofol group is denominated
as GP, the remifentanil group as GR, and the Mi-
dazolam group as GM.
The infusion regimen, aiming to obtain, a sedative
level equivalent to grades II and III on the Ramsey
Scale (Table 1), was initiated before the anesthetic
block was performed. Local anaesthesia was achieved
by inﬁltration of mepivacain hydrochloride with 2%
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adrenalin in prepackaged form (maximum, 35 ml
perpatient). Intraoperative monitoring was per-
formed using SBP (systemic blood pressure), DBP
(diastolic blood pressure), MBP (mean blood
pressure), electrocardiogram (II der.), HR (heart
rate), arterial oxyhemoglobin saturation (SpO2) fre-
quency of respiration, and an visual analog scale in-
traoperative (VAS). Eventual adverse side eﬀects
were reported (e.g., nausea vomiting ). The Students t
test was used for statistical analysis of the result.
Values of p<0.05 were considered signiﬁcant.
Results
The medium infusion regimen for the sedation level
mentioned earlier (Ramasay Scale grades II and III)
is shown in Table 2. The proposed level of sedation
was achieved for all the patients. Better hemody-
namic stability was achieved for the GR and GM
patients than for the GP patients [1,6]. Bradycardia
(45 bpm) was recorded for 20% of the GP group as
compared with 10% of the GM group and 6.6% of the
GR group. However in the latter group, the heart
rate never fell below 50 bpm. Hypertension also was
recorded in more GP patients (n = 3) than GM
(n = 2) and GR (n = 0) patients.
In 16.6% of the GM and in 20% of the GP patients,
the respiratory rate fell to fewer than 10 breathsper
minute. Consequently, it was necessary to assist
ventilation by mask for six GP and ﬁve GM patients
in spontaneous respiration because of desaturation
(SpO2, 94%), whereas this maneuver was not neces-
sary for GR patients.
The results of the study are shown in Table 3.
Statistically signiﬁcant diﬀerences were observed in a
composition (p < 0.05) of the GM and GP groups
with the group GR in terms of all the eﬀects studied,
except for nausea and vomiting. Furthermost should
be noted that superior intraoperative pain control
was demonstrated in the GR patients [7,8].
Conclusions
Most opioids reduce sympathetic and increase para-
sympathetic and vagal tones. However, these eﬀects
appear only when they are administered in boluses and
in high doses. Remifentanil does not exihibit these ef-
fects because of its pharmacokinetic properties [10]. In
this study, remifentanil provided an overall better
tolerability proﬁle than the other substances [2,5,12]. It
also oﬀered the best control of intraoperative pain,
proving to be safe and valid for use in analgosedation.
It surely improved the comfort and well-being of pa-
tients undergoing cosmetic surgery because of its more
eﬀective and lasting control of perioperative pain.
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